Investing.com - AbbVie (NYSE:ABBV) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AbbVie announced earnings per share of $3.11 on revenue of $13.96B. Analysts polled by Investing.com anticipated EPS of $3.08 on revenue of $13.63B.
AbbVie shares are up 10% from the beginning of the year and are trading at $117.40 , down-from-52-week-high.They are under-performing the S&P 500 which is up 17.65% from the start of the year.
AbbVie shares lost 1.24% in pre-market trade the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by HCA on Tuesday, July 20, 2021, who reported EPS of $4.37 on revenue of $14.44B, compared to forecasts EPS of $3.16 on revenue of $13.61B.
Centene had beat expectations on Tuesday with second quarter EPS of $1.25 on revenue of $31.03B, compared to forecast for EPS of $1.22 on revenue of $30.19B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar